Therefore, in current study, the nasopharyngeal swab samples were used in the detection of EBV LMP-1, LMP-2 expression to find out the non-invasive, potential biomarker for NPC diagnosis and screening. This evidence concerns the gene PSMB9 and nasopharyngeal carcinoma.